metabolic health

Tesamorelin for HIV Lipodystrophy Visceral Fat
Clinical Evidence & Mechanisms

Tesamorelin for HIV Lipodystrophy Visceral Fat

Tesamorelin offers FDA-approved relief for HIV lipodystrophy by targeting visceral fat accumulation, the stubborn metabolic complication that increases cardiovascular risk and diminishes quality of life in long-term antiretroviral therapy patients.

AdminJul 2412 min
Evolution of Obesity Pharmacotherapy with New Drugs
Obesity & Metabolic Health

Evolution of Obesity Pharmacotherapy with New Drugs

Explore the fascinating evolution of obesity pharmacotherapy, from early GLP-1 therapies to the groundbreaking triple agonists like tirzepatide and retatrutide, showcasing how peptide engineering has revolutionized treatment options.

AdminApr 1810 min